You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
17 February 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and Israel-based pharmaceutical company Teva Pharmaceutical Industries Ltd (NYSE:TEVA) (TASE:TEVA), on Tuesday reported positive long-term extension results fr...
17 February 2026 - First Ascent Biomedical, an oncology decision support platform, announced on Monday the official opening of a Functional Precision Medicine (FPM) laboratory in Miami, Florida.The Miami lab is now accepting patient samples through p...
17 February 2026 - Immunology company Nucleome Therapeutics announced on Monday the appointment of Dr Michelle Morrow as its chief scientific officer (CSO), effective 23 February 2026.Dr Morrow has two decades of experience in drug discovery and deve...
16 February 2026 - Medicine company Eli Lilly and Company (NYSE: LLY) on Monday reported positive topline data from the Phase 3 LIBRETTO-432 trial evaluating Retevmo (selpercatinib) as adjuvant therapy in patients with stage II–IIIA RET fusion-...
16 February 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) reported on Monday that a universal respiratory syncytial virus immunisation programme using Beyfortus (nirsevimab) was associated with a statistically signifi...
16 February 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), on Monday reported positive Phase III results from the MAJESTY study evaluating Gazyva (obinutuzumab) in adults with primary membranous nep...